- Lanatoside
- Lanatoside A
- Lanatoside B
- Lanatoside C
- 17575-26-72H-1-Benzopyran-2-one,4,5,7-trihydroxy-
- 17576-53-3Quinoline, 3-nitro-
- 17576-63-5Quinoline,3-fluoro-4-nitro-, 1-oxide
- 1757-72-81H-Indole-3-carboxaldehyde,1-methyl-2-phenyl-
- 17577-28-5Phosphonium,(2-ethoxy-2-oxoethyl)triphenyl-, chloride (1:1)
- 175774-12-6(2R,3R)-1-(Dimethylamino)-3-(3-methoxyphenyl)-2-methyl-3-pentanol hydrochloride
- 17578-36-8Phosphorothioic acid,S-[[(2,5-dichlorophenyl)thio]methyl] O,O-dimethyl ester
- 175791-49-87H-Pyrrolo[2,3-d]pyrimidine,5-bromo-
- 17579-79-22-Naphthalenol,6-methyl-
- 17582-53-5Stannane,butyltriethyl-
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
| Name |
Lanatoside A |
EINECS | N/A |
| CAS No. | 17575-20-1 | Density | 1.39g/cm3 |
| PSA | 268.05000 | LogP | 1.64230 |
| Solubility | N/A | Melting Point |
245-248°C |
| Formula | C49H76 O19 | Boiling Point | °Cat760mmHg |
| Molecular Weight | 969.131 | Flash Point | °C |
| Transport Information | N/A | Appearance | N/A |
| Safety | A deadly poison by ingestion, intraperitoneal, and intravenous routes. When heated to decomposition it emits acrid smoke and irritating fumes. | Risk Codes | N/A |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
5b-Card-20(22)-enolide, 3b-[[O-[O-(O-glucosyldigitoxosyl)digitoxosyl]digitoxosyl]oxy]-14-hydroxy-,acetate (7CI); Lanatoside A (6CI,8CI); Adigal; Digilanide A; NSC 7532 |
Lanatoside A Chemical Properties
IUPAC: [6-[4-Hydroxy-6-[4-hydroxy-6-[[14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6, 7,8,9, 11, 12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-2-methyloxan-3-yl]oxy-2-methyloxan-3-yl]oxy-2-methyl-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-4-yl] acetate
Lanatoside A with CAS NO.of 17575-20-1 is also called for 3-((O-beta-D-Glucopyranosyl-(1-4)-O-3-O-acetyl-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-14-hydroxycard-20(22)-enolide (3beta,5beta)- ; 5-18-03-00355 (Beilstein Handbook Reference) ; Adigal ; BRN 0078336 ; Digilanid A ; Digilanide A ; Digitoxigenin + 2 digitoxose + acetyl-digilanidobose ; EINECS 241-544-0 ; Lanatosid A ; NSC 7532 ; Card-20(22)-enolide, 3-((O-beta-D-glucopyranosyl-(1-4)-O-3-O-acetyl-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-14-hydroxy-, (3beta,5beta)- (9CI) and so on.
CAS: 17575-20-1
Molecular Formula: C49H76O19
Molecular Weight: 969.12
EINECS: 241-544-0
ACD/LogP: 0.96
ACD/LogD (pH 5.5): 0.96
ACD/LogD (pH 7.4): 0.96
ACD/BCF (pH 5.5): 3.15
ACD/BCF (pH 7.4): 3.15
ACD/KOC (pH 5.5): 79.12
ACD/KOC (pH 7.4): 79.12
H bond acceptors: 19
H bond donors: 7
Freely Rotating Bonds: 19
Heavy Atom Count: 68
Formal Charge: 0
Complexity: 1840
Isotope Atom Count: 0
Defined Atom StereoCenter Count: 0
Undefined Atom StereoCenter Count: 25
Defined Bond StereoCenter Count: 0
Undefined Bond StereoCenter Count: 0
Covalently-Bonded Unit Count: 1
Index of Refraction: 1.601
Molar Refractivity: 238.17 cm3
Molar Volume: 694.9 cm3
Surface Tension: 67 dyne/cm
Density: 1.39 g/cm3
The molecular structure of Lanatoside A with CAS NO.of 17575-20-1:
Lanatoside A Uses
Lanatoside A (CAS NO.17575-20-1) is used to treat congestive heart failure and a variety of rapid supraventricular arrhythmia.
Lanatoside A Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| cat | LDLo | intravenous | 220ug/kg (0.22mg/kg) | Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 184, Pg. 181, 1937. | |
| guinea pig | LD50 | oral | 100mg/kg (100mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 15, Pg. 481, 1965. | |
| guinea pig | LDLo | intravenous | 1040ug/kg (1.04mg/kg) | British Journal of Pharmacology and Chemotherapy. Vol. 18, Pg. 311, 1962. | |
| mouse | LD50 | intracrebral | 32ug/kg (0.032mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Arzneimittel-Forschung. Drug Research. Vol. 11, Pg. 908, 1961. |
| mouse | LD50 | intraperitoneal | 20mg/kg (20mg/kg) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 155, Pg. 165, 1965. | |
| mouse | LD50 | intravenous | 21300ug/kg (21.3mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Arzneimittel-Forschung. Drug Research. Vol. 11, Pg. 908, 1961. |
| mouse | LD50 | oral | 9340ug/kg (9.34mg/kg) | Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 54, Pg. 58, 1958. | |
| rat | LD50 | intravenous | 16mg/kg (16mg/kg) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 155, Pg. 165, 1965. |
Lanatoside A Safety Profile
A deadly poison by ingestion, intraperitoneal, and intravenous routes. When heated to decomposition it emits acrid smoke and irritating fumes.
What can I do for you?
Get Best Price
